Trial intelligence / Profile preview

Albumin vs HES for Endothelial Injury in Cardiac Surgery

NCT02882074Completed

Sponsor
Cleveland Clinic
Start
Jun 2016
Primary completion
Feb 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial of albumin (human) in hypovolemia (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Reactive Hyperemia Index. Started Jun 2016; status: completed.

02

Drugs

albumin (human)
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT02882074.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02882074.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call